Janus
- 22 Jan 2004 08:19
goldfinger
- 17 Feb 2004 23:53
- 49 of 145
Down a tad today. Im keeping faith with this one. Its usually the case that the big boys in the US mess the little ones around for a while before agreeing on a contract. May even add as this certainly is not a one trick pony. Just been looking again at the news to come and it appears newsflow will keep this one going all the year through.
cheers GF.
overgrowth
- 18 Feb 2004 00:03
- 50 of 145
GF,
I agree, this one looks better the more research you do, and talking of research and the imminent prospects of MDW's hard labours bearing many baskets of fruit, I noticed an audio interview by the Wall Street Reporter made on 21st Jan this year with the CEO.
Here's the link for anyone who hasn't heard it yet:
http://www.wallstreetreporter.com/profiles/Mediwatch.html
goldfinger
- 18 Feb 2004 10:26
- 51 of 145
Well done overgrowth thats a fine piece of research. Added again this morning and now forming a nice position within this company. Dont think many have realised just how big this one could be.
cheers GF.
Janus
- 18 Feb 2004 12:51
- 52 of 145
Many thanks overview. I hadnt heard this one before
goldfinger
- 22 Feb 2004 20:52
- 54 of 145
Will we get the distribution deal this week, any one with any info???????
cheers GF.
Oakapples
- 23 Feb 2004 09:45
- 55 of 145
Me too - this is currently my big loser
kantona
- 23 Feb 2004 15:05
- 56 of 145
the share price now is coming back up .. i personally think there was bound to be some profit taking after such a strong run ..this vll come good ..just a case of being patient and strong
kantona
- 23 Feb 2004 15:05
- 57 of 145
goldfinger
- 23 Feb 2004 16:26
- 58 of 145
Yes patience, probably the most valuable tool when investing.
cheers GF.
goldfinger
- 23 Feb 2004 21:15
- 60 of 145
Couldnt agree more overgrowth. Too many people panic on short term movements.
cheers GF.
scotinvestor
- 23 Feb 2004 21:19
- 61 of 145
i bought in at just under 10p so no panic for me as yet. However, looking at chart, i think we are due another big hike up very soon. Any experienced chartists out there to back up my claims
goldfinger
- 25 Feb 2004 00:01
- 62 of 145
Not a chartist scotinvestor just hoping the do manage to rally.
cheers GF.
overgrowth
- 25 Feb 2004 00:45
- 63 of 145
The one month candlestick chart shows the recent trend turning bullish again:
The dragonfly doji (horizontal line with vertical underneath) is a respected bullish sign after a downtrend. This means that support brought the price back up to where it started from.
The hammer (rectangle with long vertical underneath) is also well-known as a bullish signal, heralding the "hammering up" of the price imminently - note that this powering up of bullishness does not always happen in the next session, but is sure to follow soon. This hammer also emphasises very strong support at 11.5p.
So, it looks like the chart is saying that the deal could be announced before the end of the week. If this is not the case, then it looks as though there will be renwed bullish interest in the prospects of the company in general (or in anticipation of the deal or a host of other reasons which TA's don't care about anyway when looking at the charts).
kantona
- 25 Feb 2004 22:48
- 64 of 145
like i said before if this one goes down further take it as an opprtunity to top up ..least thats what i feel ..
just to refresh our memory here is the last RNS re the FDA approval ..the important info is in the last paragraph and i quote from there..
"We are in advanced stages to conclude a distribution agreement with a large, well-established international company that is already selling into closely related markets" ..so i for one not yet concerned about the currrent downward pressure on price ..just a matter of time b4 details r released .. i'm holding as long as it takes.
Mediwatch PLC
20 January 2004
Mediwatch Secures FDA Marketing Approval for Portascan(R)
Rugby, UK - 20 January, 2004 - Mediwatch, the innovative UK manufacturer of high
tech screening and diagnostic systems for urological disorders, announced today
that it has received marketing approval from the US Food and Drug Administration
(FDA) for the Portascan(R) portable bladder scanner in the USA.
The state-of-the-art portable diagnostic will be used to screen patients
suffering from prostate and bladder disorders, incontinence and those requiring
catheterization. Doctors' offices, outpatient clinics, hospital emergency
departments and nursing homes are all potential users of the Portascan, where
its level of accuracy gives it a major advantage over its competitors This
approval provides Mediwatch with access to the lucrative US bladder screening
market, currently valued at between $15 and $20 million per annum.
Commenting on this development, Philip Stimpson, CEO, said, 'Breaking into the
US market represents a significant milestone for Mediwatch. We are in advanced
stages to conclude a distribution agreement with a large, well-established
international company that is already selling into closely related markets.
Although this is our first venture into the US, we have already signed similar
agreements with multi-nationals to distribute our products across Europe.'
scotinvestor
- 26 Feb 2004 13:09
- 65 of 145
many people must be losing a lot on this one already. i noticed people on this buying at 13-14 p levels. you have to sell at 11p already.
i'm still going to sit this one out just like i did with RTD. if u believe in something, then stick by it. the day traders stuff up small cap shares like this one but long term they cant do anything.
grajul
- 26 Feb 2004 13:43
- 66 of 145
could not agree more scotinvestor. This is a good company and will recover I am sure. I will be sitting this one out.